Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Adaptimmune's Q4 and Full Year 2024 Business Update Conference Call. As a reminder, all participants are in a listen-only mode. The conference is being recorded.